Try for free

ADP ON00323E: Real-Time CGM (rtCGM) Funding Form

Ontario's Assistive Devices Program uses this form to fund a real-time continuous glucose monitor for people with type 1 diabetes who meet set hypoglycemia-risk criteria, with one form for adults and children. A specialist physician or nurse practitioner linked to an ADP-registered Diabetes Education Program confirms eligibility and signs. ADP then covers sensors and transmitters in full, paid to the vendor, up to a maximum quantity per 24 months.

Who completes it

Section 2 (Eligibility) must be completed by an endocrinologist, another specialist physician or a nurse practitioner associated with a diabetes program, who also signs Section 4 and names the Diabetes Education Program and its ADP clinic number. The applicant or agent completes Sections 1 and 3, and the ADP-registered vendor completes the vendor block.

Submitting and payment

How to submit it
Diabetes Education Program staff help complete the form and send it to an ADP-registered rtCGM vendor, which submits it to ADP electronically. Attachments are not considered, and the information sheet estimates two to four weeks for review.
Who pays
The form lists no prescriber fee; ADP pays the rtCGM vendor directly for full coverage of sensors and transmitters up to the maximum allowable quantity for each 24-month period.

Good to know

  • Beyond type 1 diabetes, the patient must be unable to recognize or communicate hypoglycemia or to do fingerstick testing, or have had qualifying severe hypoglycemia in the past 2 years.
  • Qualifying severe hypoglycemia has no obvious precipitant, occurs despite optimized insulin and testing at least 4 times a day, and led to licence suspension, hospital, emergency or EMS care, glucagon, unconsciousness or seizure.
  • All applicants must commit to long-term follow-up with the program, full-time rtCGM wear, and sharing Ambulatory Glucose Profile data such as time in range with the care team.
  • Coverage renews every two years on Renewal Form ON00421E, supplied by the vendor; renewal requires wearing the rtCGM at least 70% of the time and regular diabetes follow-up.

Get the official form

Download the current version from the source each time; forms change without notice.

Application for Funding Real-Time Continuous Glucose Monitoring System (rtCGM)

Demande d'aide financière pour surveillance du glucose en continu (SGC) en temps réel

Official pagePDFVersion française

Fill it with Vero

Upload the fillable PDF once and Vero Documents fills it from the visit note and the chart, ready for you to review and sign. Download, print, or email the finished form, with the patient’s consent.

See how Vero Documents works

How this list is checked

A form is listed only after its name and number were confirmed on the issuing agency’s or insurer’s own website, or in the form itself. Each entry links to that source. The list was last checked in October 2026. Forms change without notice, so download the current version from the official page before you fill it in.

Vero is not affiliated with, or endorsed by, the agencies and insurers listed here. Read our editorial policy.

Frequently asked questions

Who can sign the ADP rtCGM application?

The Section 4 prescriber must be a physician or nurse practitioner certifying that the applicant has type 1 diabetes and meets the Section 2 criteria. The form specifies an endocrinologist, another specialist physician, or a nurse practitioner associated with one of the diabetes programs registered with ADP.

Can a patient with an ADP-funded insulin pump get rtCGM coverage?

Yes. If the insulin pump uses rtCGM technology, the patient may be eligible for ADP coverage of the sensors and transmitters. According to the applicant information sheet, they still need to meet the device-specific rtCGM medical criteria and submit this application form.

Is the rtCGM application available in French?

Yes. The Central Forms Repository posts ON00323E in English and French, each with an applicant information sheet. Both are XFA fillable PDFs that show only a placeholder message in browsers, so open them in a current version of Adobe Acrobat or Reader.